Correlation Between Faron Pharmaceuticals and Moonpig Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Faron Pharmaceuticals and Moonpig Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Faron Pharmaceuticals and Moonpig Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Faron Pharmaceuticals Oy and Moonpig Group PLC, you can compare the effects of market volatilities on Faron Pharmaceuticals and Moonpig Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Faron Pharmaceuticals with a short position of Moonpig Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Faron Pharmaceuticals and Moonpig Group.

Diversification Opportunities for Faron Pharmaceuticals and Moonpig Group

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Faron and Moonpig is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Faron Pharmaceuticals Oy and Moonpig Group PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moonpig Group PLC and Faron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Faron Pharmaceuticals Oy are associated (or correlated) with Moonpig Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moonpig Group PLC has no effect on the direction of Faron Pharmaceuticals i.e., Faron Pharmaceuticals and Moonpig Group go up and down completely randomly.

Pair Corralation between Faron Pharmaceuticals and Moonpig Group

Assuming the 90 days trading horizon Faron Pharmaceuticals Oy is expected to generate 1.54 times more return on investment than Moonpig Group. However, Faron Pharmaceuticals is 1.54 times more volatile than Moonpig Group PLC. It trades about -0.01 of its potential returns per unit of risk. Moonpig Group PLC is currently generating about -0.08 per unit of risk. If you would invest  17,500  in Faron Pharmaceuticals Oy on September 24, 2024 and sell it today you would lose (1,000.00) from holding Faron Pharmaceuticals Oy or give up 5.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Faron Pharmaceuticals Oy  vs.  Moonpig Group PLC

 Performance 
       Timeline  
Faron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Faron Pharmaceuticals Oy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Moonpig Group PLC 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moonpig Group PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Moonpig Group may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Faron Pharmaceuticals and Moonpig Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Faron Pharmaceuticals and Moonpig Group

The main advantage of trading using opposite Faron Pharmaceuticals and Moonpig Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Faron Pharmaceuticals position performs unexpectedly, Moonpig Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moonpig Group will offset losses from the drop in Moonpig Group's long position.
The idea behind Faron Pharmaceuticals Oy and Moonpig Group PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities